We previously developed and validated informatic algorithms that used International Classification of Diseases 9th revision (ICD9)–based diagnostic and procedure codes to detect the presence and ...

Researchers have proposed a machine-learning algorithm for personalized treatment selection in patients with recurrent hepatocellular carcinoma, based on data published in JAMA Surgery. “Several ...

Omitting race and ethnicity from colorectal cancer (CRC) recurrence risk prediction models could decrease their accuracy and fairness, particularly for minority groups, potentially leading to ...

Please provide your email address to receive an email when new articles are posted on . A diagnostic algorithm for classifying chronic rhinosinusitis demonstrated utility in determining refractoriness ...

WEST LAFAYETTE, Ind. — A Purdue University professor and several international researchers have developed a new method and algorithm that can predict the recurrence of prostate cancer in patients ...

Mayo Clinic researchers in Phoenix used artificial intelligence to create an algorithm to better predict colorectal cancer recurrence, according to a multinational study published in Gastroenterology.

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company applying innovative diagnostics to inform disease management decisions and improve patient outcomes, today ...

At the San Antonio Breast Cancer Symposium, researchers presented findings on Clarity BCR, a multimodal multitask ...

Predictions for identifying 1-year seizure recurrence performed significantly better in electroencephalography (EEG) without interictal epileptiform discharges. An automated processing algorithm ...

Approximately 20% to 30% of men with prostate cancer experience disease recurrence within 5 years of therapeutic intervention. 1 A key challenge in managing these patients is a scarcity of accurate ...

Helsinki, Finland - A new risk model developed by European researchers is able to accurately predict vascular events, including stroke, MI, and vascular death, in patients with existing clinical ...